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Emily M. James, MS 
University of Pittsburgh, 2007
 
 
Bipolar disorder (BPD) is a serious mood disorder that affects about 1% of the population of the 
United States.  Twin, family, and adoption studies have shown evidence for a genetic component 
of BPD, but monozygotic twin concordance is less than one, indicating that BPD is a 
mulitfactorial disorder.  First-degree relatives of an individual with BPD have approximately a 3-
15% risk of developing BPD because of shared genes and environment.  No strong genetic 
susceptibility loci for BPD have been located, although some regions of interest are currently 
being evaluated.  With increasing genetic information, it is expected that demand for genetic 
counseling for BPD and other psychiatric disorders will increase.  This project is relevant to 
public health because BPD is a common disorder with a significant disease burden.  
Understanding the needs and concerns of the patient population can help tailor care and reduce 
the burden of the disease. 
Using anonymous surveys and a semi-structured interview for individuals with BPD and 
their first-degree relatives, the knowledge, opinions, and acceptance of genetic counseling in this 
population have been studied.  The Health Belief Model was used to assess current health beliefs 
relating to BPD.  Additionally, using a brief educational session, the effect of education on 
knowledge and health beliefs was assessed. 
Preliminary data show that the perceived severity of BPD, susceptibility to BPD, and 
perceived benefit of genetic information were high at 4.33, 4.45, and 4.36 out of 5, respectively, 
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while the cumulative perceived barriers to testing were moderate to high at 3.09 out of 5.  
Preliminary data also show that the knowledge of BPD in affected individuals is high at 7 
(±1.15) out of 8. 
 v 
TABLE OF CONTENTS 
PREFACE....................................................................................................................................XI 
INTRODUCTION..................................................................................................................... XII 
1.0 SPECIFIC AIMS.......................................................................................................... 1 
1.1 SPECIFIC AIM I................................................................................................. 1 
1.2 SPECIFIC AIM II ............................................................................................... 1 
1.3 SPECIFIC AIM III.............................................................................................. 2 
2.0 BACKGROUND AND SIGNIFICANCE .................................................................. 4 
2.1 BIPOLAR DISORDER (BPD) EPIDEMIOLOGY.......................................... 4 
2.1.1 Prevalence of bipolar disorder..................................................................... 4 
2.1.2 Age-at-onset ................................................................................................... 5 
2.2 DIAGNOSIS......................................................................................................... 6 
2.2.1 Diagnosis of bipolar I disorder .................................................................... 6 
2.2.2 DSM-IV Definition: Manic episode............................................................. 6 
2.2.3 DSM-IV Definition: Major depressive episode .......................................... 8 
2.2.4 DSM-IV Definition: Mixed episode............................................................. 9 
2.2.5 Subclassifications and specifiers for the diagnosis of bipolar disorder ... 9 
2.2.6 Diagnosis of bipolar II disorder................................................................. 10 
2.2.7 Diagnosis of bipolar disorder not otherwise specified............................. 11 
 vi 
2.2.8 Differential diagnosis .................................................................................. 11 
2.3 DESCRIPTIVE FEATURES OF BPD ............................................................ 12 
2.4 TREATMENT.................................................................................................... 13 
2.5 RISK FACTORS ............................................................................................... 14 
2.6 COMPLEX GENETIC DISORDERS ............................................................. 16 
2.7 EVIDENCE FOR A GENETIC COMPONENT IN BPD AND EMPIRIC 
RISK 16 
2.8 GENETICS......................................................................................................... 17 
2.8.1 Genetic counseling ...................................................................................... 19 
2.8.2 Genetic counseling for psychiatric disorders ........................................... 21 
2.8.3 Genetic counseling providers ..................................................................... 26 
2.8.4 Understanding of the genetic and environmental contributions to BPD27 
2.8.5 Demand for genetic counseling .................................................................. 27 
2.8.6 Demand for genetic testing......................................................................... 28 
2.8.6.1 Presymptomatic testing in adults ...................................................... 28 
2.8.6.2 Confirmatory genetic testing in adults ............................................. 29 
2.8.6.3 Presymptomatic or confirmatory testing in children ...................... 29 
2.8.6.4 Prenatal genetic testing ...................................................................... 31 
2.8.6.5 Perceived benefits and risks of genetic testing for BPD.................. 33 
2.8.6.6 Other feelings toward genetic testing for BPD................................. 34 
2.8.6.7 Health beliefs and BPD ...................................................................... 35 
3.0 MATERIALS AND METHODS .............................................................................. 39 
3.1 DESIGN AND RATIONALE ........................................................................... 39 
 vii 
3.2 PARTICIPANTS ............................................................................................... 39 
3.3 EXPERIMENTAL DESIGN ............................................................................ 41 
3.4 DATA ANALYSIS............................................................................................. 42 
4.0 RESULTS ................................................................................................................... 44 
4.1 DEMOGRAPHICS............................................................................................ 44 
4.2 SPECIFIC AIM I............................................................................................... 47 
4.3 SPECIFIC AIM II ............................................................................................. 51 
4.4 SPECIFIC AIM III............................................................................................ 51 
5.0 DISCUSSION ............................................................................................................. 52 
APPENDIX A: IRB APPROVAL LETTER ............................................................................ 56 
APPENDIX B: SURVEYS ......................................................................................................... 58 
APPENDIX C: EDUCATIONAL SESSION OUTLINE ........................................................ 67 
BIBLIOGRAPHY....................................................................................................................... 69 
 viii 
 LIST OF TABLES 
 
Table 1: Empiric Risks, reviewed by the NSGC Psychiatric Special Interest Group (19)........... 17 
Table 2: Variables Used in the Health Belief Model.................................................................... 36 
Table 3: Summary of Current Health Beliefs (Affected Individuals, N=4) ................................. 49 
Table 4: Sample of Responses to Open-ended Question 1 ........................................................... 50 
 ix 
LIST OF FIGURES 
 
Figure 1: Age Distribution of Preliminary Survey Participants.................................................... 45 
Figure 2: Marital Status of Preliminary Survey Participants ........................................................ 45 
Figure 3: Number of Children for Preliminary Survey Participants............................................. 46 
Figure 4: Highest Level of Education Completed Among Preliminary Survey Participants ....... 46 
Figure 5: Time of Diagnosis for Affected Individuals Completing the Preliminary Survey........ 47 
 x 
PREFACE 
I would like to thank my thesis committee Elizabeth Gettig, MS, CGC, Robin Grubs, PhD, CGC, 
and Vishwajit Nimgaonkar, MD, PhD for their support and guidance throughout the past two 
years.  This project would not have been successful without each of you.  Thank you to Patrick 
Reitz and Sue Clifton from the University of Pittsburgh Bipolar Study for your assistance in 
recruitment.  Finally, thank you to Triptish Bhatia for working with me to design this study.  I 
wish you continued success in your research. 
 
 
 
 
 
 
 
 
 
 
 xi 
INTRODUCTION 
The Masters Thesis project that follows was originally designed for fifty or more participants.  
To date, four participants have completed the survey and two have completed the educational 
session and follow-up survey.  The preliminary data have been analyzed and interpreted to this 
point, although the strength of the interpretations will be higher when more participants are 
added.  Within one calendar year of the date of submission, more participants will be enrolled, 
and the results and discussion of this Masters Thesis will be updated to reflect the original 
design. 
 xii 
1.0  SPECIFIC AIMS 
1.1 SPECIFIC AIM I 
Specific Aim: To determine the current health beliefs of those diagnosed with bipolar disorder 
(BPD) and the current health beliefs of their first degree relatives, in regard to cause, course, 
treatment, and genetic information.    
Hypothesis: Participants will have a low level of knowledge about cause, high level of perceived 
severity of mental illness, and a low level of perceived susceptibility.   Identifying the current 
status of health beliefs will determine areas of education that must be stressed in order to 
increase knowledge. 
Plan: Utilizing anonymous surveys among those diagnosed with bipolar disorder, and their first 
degree relatives, the following topics were analyzed: the current state of knowledge of cause, 
course, treatment, and genetic information. Assessment of knowledge of psychiatric genetic risks 
was also studied to determine if a correlation exists with health beliefs. 
1.2 SPECIFIC AIM II 
Specific Aim:  To assess participants’ knowledge of genetic counseling, and to assess 
acceptance of and interest in genetic counseling services and genetic testing. 
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Hypothesis:  Participants will have a high level of perceived benefit to testing, a low level of 
perceived barriers to testing, a low level of perceived impact of genetic susceptibility 
information, and a low level of knowledge of and interest in genetic counseling. Identifying the 
current status of knowledge and acceptance will determine areas of education that must be 
stressed in order to increase knowledge and acceptance. 
Plan:  Utilizing anonymous surveys among those diagnosed with bipolar disorder and their first 
degree relatives, the current state of knowledge of genetic testing and genetic counseling, and 
acceptance of genetic counseling services was ascertained.  
1.3 SPECIFIC AIM III 
Specific Aim: To improve the knowledge and acceptance of genetic testing and genetic 
counseling for psychiatric conditions through individual education sessions.  
Hypothesis: The lack of interest in genetics may be due to a lack of knowledge of genetics and 
the risks associated with bipolar disorder. Acceptance can be improved by increasing the 
communities’ knowledge of hereditary concepts. Acceptance of and interest in genetic 
counseling services may also increase. 
Plan: Utilizing anonymous surveys, assessment of knowledge of bipolar disorder and acceptance 
of genetic testing and genetic counseling for psychiatric conditions was performed prior to and 
following the administration of a brief individual educational session. A didactic session 
included (1) taking a psychiatric family history to facilitate risk assessment when necessary, (2) 
discussing complex inheritance, genes, molecular testing, and the availability, risks, benefits, and 
limitations of genetic testing, and (3) calculating recurrence risks, if possible. The effectiveness 
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of the educational session was analyzed as well as the relationship of knowledge of psychiatric 
conditions with acceptance of genetic testing. 
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2.0  BACKGROUND AND SIGNIFICANCE 
The overall goal of this project was to learn more about the needs of the population touched by 
BPD, anticipating that the demand for genetic counseling services for psychiatric disorders will 
grow in the future.  In order to address these issues, it was necessary to review the diagnosis and 
features of BPD, the current understanding of genetic and environmental risk factors, the 
literature regarding genetic counseling for psychiatric conditions, and published studies that have 
examined the opinions of this population to date. 
2.1 BIPOLAR DISORDER (BPD) EPIDEMIOLOGY 
2.1.1 Prevalence of bipolar disorder 
Estimates of the lifetime prevalence of bipolar I disorder vary from 0.3% to 1.6% of the 
population in the United States. (1, 2)  The lifetime prevalence of bipolar II disorder is estimated 
at 0.5%. (3)  Bipolar I disorder, bipolar II disorder, and bipolar disorder not otherwise specified 
are discussed as separate diagnoses only when the distinction is clear, and only in the 
background and significance.  Otherwise in this document, bipolar disorder or BPD includes the 
entire bipolar spectrum.  For the purpose of this study, no distinction was made between types of 
BPD. 
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There is no statistically significant difference in prevalence between different ethnic 
groups. (2)  A number of studies have compared the prevalence between the sexes, and have 
found no statistically significant difference. (1, 2)  However, some differences in the course of 
BPD exist between the sexes.  For example, in males, the first episode is more likely to be a 
manic episode.  Also, the number of manic and major depressive disorders is likely to be even, 
or, if a difference is observed, the number of manic episodes is likely greater.  In females, the 
first episode is more likely to be a major depressive episode, and the number of major depressive 
episodes is often greater than the number of manic episodes. (2)  
2.1.2 Age-at-onset 
The average age-at-onset of BPD ranges from 18 years in the United States to 27 years in Puerto 
Rico. (1)  While the first symptoms of BPD can appear at almost any age, there appears to be a 
peak period of onset between 15 and 19 years of age in the United States. (4)  In a survey by the 
National Depressive and Manic-Depressive Association, 59% of respondents first experienced 
symptoms during childhood or adolescence.  Only 16% of respondents first experienced 
symptoms after age 30. (5)  Clinicians may mistakenly diagnose schizophrenia in some 
individuals with BPD, especially in some ethnic groups and in the younger population. (2) 
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2.2 DIAGNOSIS 
2.2.1 Diagnosis of bipolar I disorder 
The diagnosis of BPD is based on criteria in the Diagnostic and Statistical Manual IV (DSM-IV).  
Diagnosis is based solely on clinical features.  There are no laboratory features diagnostic for 
BPD, but individuals with BPD tend to have more right-hemispheric, bilateral subcortical, and 
periventricular lesions on imaging studies.   
Bipolar I disorder is characterized by the occurrence of one or more manic or mixed 
episodes. Often individuals have one or more major depressive episodes.  Episodes of mood 
disorder due to the direct effects of a drug, medication, toxin, or a somatic treatment for 
depression, or those directly attributable to another medical condition, do not count toward a 
diagnosis of bipolar I disorder. In addition, the episodes are not better accounted for by 
schizoaffective disorder and cannot also apply to a diagnosis of schizophrenia, schizophreniform 
disorder, delusional disorder, or psychotic disorder not otherwise specified. (2, 6) 
2.2.2 DSM-IV Definition: Manic episode 
A manic episode is a distinct period of abnormally and persistently elevated, expansive, or 
irritable mood lasting at least one week, or requiring hospitalization.  Diagnosis of a manic 
episode requires three additional symptoms (if the mood is elevated or expansive) or four 
additional symptoms (if the mood is irritable) from a list including: inflated self-esteem or 
grandiosity which may reach delusional proportions, decreased need for sleep, pressure of 
speech, flight of ideas, distractibility or inability to screen out irrelevant stimuli, increased 
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involvement in goal-directed activities or psychomotor agitation, and excessive involvement in 
pleasurable activities with high potential for painful consequences. (6) 
Decreased need for sleep is very common.  During a manic episode, individuals may go 
several days without sleep or regularly awaken early.  Pressure of speech includes speech that is 
loud, rapid, and difficult to interpret.  Speech may include joking, theatrics, or complaining to an 
unusual extent.  Flight of ideas often involves thoughts coming faster than they can be articulated 
or disorganized speech.  Excessive involvement in pleasurable activities may include buying 
sprees, reckless driving, foolish business investments, or unusual sexual behavior.  In order to be 
sufficient for the diagnosis, these behaviors must cause marked impairment in social or 
occupational functioning, require hospitalization, or include psychotic features.  Individuals 
often do not recognize that they are ill and resist treatment. (6) 
In 1978, Krauthammer and Klerman introduced the concept of secondary mania.  This is 
a manic episode secondary to a medical disorder or drug use.   Because bipolar disorder has a 
high rate of comorbidity with substance abuse, it can be difficult to differentiate between 
secondary mania and manic episodes consistent with bipolar disorder.  Some of the possible 
causes of secondary mania include abuse of amphetamines, caffeine, cocaine, and 
methylphenidate; withdrawal from ethanol, monoamine oxidase inhibitors, sympathomimetic 
agents, or tricyclic antidepressants; use of antidepressants and steroids; toxic metabolic states 
associated with hyperthyroidism or electrolyte abnormalities; central nervous system disorders 
including multiple sclerosis, brain tumors, sleep deprivation, damage to the right (nondominant) 
hemisphere, or temporal lobe seizures; and infections including encephalitis, syphilis of the 
central nervous system, or sepsis. (7) 
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2.2.3 DSM-IV Definition: Major depressive episode 
The essential feature of a major depressive episode is a period of at least two weeks with a 
depressed mood or loss of interest or pleasure in nearly all activities.  During the episode, the 
symptoms must be present nearly every day for most of the day.  Depression may be reported by 
the individual or observed by others.  The DSM-IV diagnosis requires at least four additional 
symptoms from the following list: changes in appetite, weight, sleep, or psychomotor activity; 
decreased energy; feelings of worthlessness or guilt; difficulty thinking, concentrating, or 
making decisions; or recurrent thoughts of death or suicidal ideation, plans, or attempts. (8) 
The appetite is usually reduced but may be increased and include food cravings.  
Therefore the individual may experience loss or gain of weight.  Some individuals first present 
because of sleep disturbances.  Insomnia is more frequent than hypersomnia.  Feelings of 
worthlessness or guilt are marked by unrealistic negative evaluations of one’s worth, 
preoccupation with minor past failings, and/or exaggerated sense of responsibility for events. (8) 
For a diagnosis of a major depressive episode, the symptoms must be new or clearly 
worsened compared to the previous emotional state of the affected person.  The symptoms must 
cause distress, impairment, or markedly increased effort in social, occupational, or other 
important areas of functioning.  In children and adolescents, depression may present as 
irritability rather than sadness.  Some individuals report somatic complaints rather than 
depression. (8) 
Symptoms do not count toward diagnosis of a major depressive episode if they are 
completely explained by another medical condition, when they are due to delusions or 
hallucinations, when they are the result of drug abuse, medication or treatment, or exposure to a 
toxin, or if they symptoms occur within two months of the loss of a loved one (unless they are 
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accompanied by marked functional impairment or other severe symptoms distinct from 
bereavement). (8) 
There are no laboratory tests that may be used to diagnose a major depressive episode, 
but 40-60% of outpatients and up to 90% of inpatients have sleep EEG abnormalities.  
Additionally, there may be disregulation of neurotransmitter systems and neruopeptides, 
including serotonin, norepinepherine, dopamine, acetylcholine, and gamma-aminobutyric acid. 
(8) 
2.2.4 DSM-IV Definition: Mixed episode 
A mixed episode is a period of time, lasting at least one week, in which the criteria for both a 
major depressive episode and a manic episode are met nearly every day.  The mood changes 
rapidly, and common features include agitation, insomnia, appetite dysregulation, psychotic 
features, suicidal thinking, and disorganized thinking and behavior.  This may occur as a new 
episode or may evolve from a major depressive episode or manic episode. (9) 
2.2.5 Subclassifications and specifiers for the diagnosis of bipolar disorder 
The diagnosis may be subclassified based on whether the current episode is the first episode or a 
recurrence and based on the most recent episode type (hypomanic, manic, mixed, depressed, or 
unspecified).  Recurrence is defined as a shift in the polarity of an episode or a two month, or 
more, interval between episodes.  Further specifiers may be used to describe the features of the 
most recent episode.  These include: mild, moderate, severe; without or with psychotic features; 
with catatonic features; with postpartum onset; in partial or full remission; chronic; with 
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melancholic features; with atypical features; and/or with rapid cycling.  The pattern of episodes 
can be specified as with or without full interepisode recovery, with seasonal pattern, or with 
rapid cycling. (2)   
When an individual has had an episode with psychotic features, they are more likely to 
experience psychotic features in future episodes.  Rapid cycling occurs in 5-15% of affected 
individuals.  It is characterized by four or more mood episodes within a given year.  BPD with 
rapid cycling is associated with a poor prognosis. (2) 
2.2.6 Diagnosis of bipolar II disorder 
Bipolar II disorder is characterized by:  
• Criterion A: one or more major depressive episodes 
• Criterion B: at least one hypomanic episode 
• Criterion C: absence of manic or mixed episodes 
• Criterion D: symptoms are not better-explained by substance-induced mood disorder, 
mood disorder due to a general medical condition, schizophrenia, schizophreniform 
disorder, delusional disorder, or psychotic disorder not otherwise specified. 
• Criterion E: symptoms cause significant distress or impairment of social, occupational, or 
other important areas of functioning.   
Specifiers are the same as those used for bipolar I disorder. (3)  The distinction between bipolar I 
disorder and bipolar II disorder is that manic or mixed episodes are absent in bipolar II disorder.  
For the diagnosis, there must have been one major depressive episode and one hypomanic 
episode.  If an individual has a manic episode, they will have a diagnosis of bipolar I disorder. 
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There is evidence to support the distinction between bipolar I disorder and bipolar II 
disorder, but some still question the distinction and await more evidence. (10) 
2.2.7 Diagnosis of bipolar disorder not otherwise specified 
The diagnosis of bipolar disorder not otherwise specified (NOS) may be used when it is unclear 
which type of bipolar disorder is emerging or in the case of rapid alternation between manic and 
depressive symptoms.  The alternation is so rapid that the episodes do not meet the minimal 
duration criteria for a manic episode or major depressive episode. (3) 
2.2.8 Differential diagnosis 
The differential diagnosis includes mood disorder due to a general medical condition.  In this 
disorder, episodes are the direct physiological result of a medical condition such as multiple 
sclerosis, stroke, or hypothyroidism.  In a substance-induced mood disorder, symptoms are 
associated with, and fully explained by, intoxication with or withdrawal from a drug or therapy.  
If the symptoms are not completely attributable to the substance, they can count toward the 
diagnosis of BPD.  The differential diagnosis also includes major depressive disorder, dysthymic 
disorder, cyclothymic disorder, and psychotic disorders.  Cyclothymic disorder is distinguished 
from BPD by the absence of manic or mixed episodes.  Instead, the individual may have 
numerous periods of hypomanic symptoms.  In psychotic disorders (schizophrenia, 
schizoaffective disorder, delusional disorder), psychotic symptoms occur without acute mood 
disorder. (3) 
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2.3 DESCRIPTIVE FEATURES OF BPD 
Before maintenance treatment, the frequency of episodes was on average four episodes in ten 
years.  Between acute episodes, about 60% of individuals with BPD experience interpersonal and 
occupational difficulties, and 20-30% of individuals with BPD experience mood swings. 10-15% 
of individuals with BPD commit suicide.  Suicidal ideation and attempts more often occur during 
a depressed or mixed episode. School truancy, school failure, occupational failure, divorce, and 
episodic antisocial behavior are common. (2) 
After one manic episode, 90% of individuals will have another episode, demonstrating 
the chronic nature of BPD. Child abuse, spousal abuse, and violent behavior more often occur 
during manic episodes or in an episode with psychotic features. (2) 
BPD is associated with an increased incidence of a number of comorbid disorders.  
Associations are observed with anorexia nervosa, bulimia nervosa, attention-deficit/hyperactivity 
disorder, panic disorder, social phobia, and alcohol and other substance abuse disorders. (2) 
More than 60% of individuals with bipolar I disorder and more than 50% of those with bipolar II 
disorder report a history of substance abuse.  The most commonly abused substances are alcohol 
and stimulants, such as amphetamines and cocaine.  Almost one third of individuals with bipolar 
I disorder and one fifth of those with bipolar II disorder report alcohol dependence. (11)  Earlier 
onset BPD is a predictor of the likelihood of later alcohol or substance abuse.  Individuals with 
BPD and alcoholism and another substance abuse disorder are more likely to have increased 
hospitalizations and more severe illness. (2) 
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2.4 TREATMENT 
Treatment guidelines for BPD were published in the Expert Consensus Guideline Series: 
Medication Treatment of Bipolar Disorder 2000.  Use of a mood stabilizer is recommended in all 
phases of treatment.  The primary mood stabilizers for acute and preventive treatment of mania 
are divalproex and lithium.  Monotherapy should be attempted first, using divalproex or lithium, 
followed by combination therapy if necessary.  The leading alternative mood stabilizer for mania 
is carbamezepine.  Other new anticonvulsants are recommended only if divalproex, lithim, and 
carbamezepine fail or are contraindicated. (12) 
Additional medication may be needed during major depressive episodes.  For mild 
depression, the recommended mood stabilizers are lithium, divalproex, and lamotrigine.   For 
severe depression, treatment includes one of these mood stabilizers along with an antidepressant 
(bupropion, serotonin reuptake inhibitor (SSRI), or venlafaxine).  Antidepressants should be 
tapered off, if possible, two to six months after resolution of the depressive episode. (12) 
For rapid cycling BPD, the recommended initial treatment for depression and mania is 
monotherapy with divalproex.  For BPD with psychotic episodes, antipsychotics are 
recommended.  Atypical antipyschotics like olanzapine and resperidone are preferred to 
conventional antipsychotics.  Other treatments may include electroconvulsive therapy (ECT), 
clozapine, thyroid hormone, or stimulants. (12) 
Unfortunately, current treatments are not effective in all individuals and have undesirable 
side effects in many individuals. (10)  Side effects for many of the mood stabilizers include 
weight gain, unpleasant taste, mild fatigue, nasal congestion, increased appetite for sweets, 
headache, dryness of the mouth, dizziness, or decreased sweating. 
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2.5 RISK FACTORS  
Much research has been done examining the risk factors that increase susceptibility to BPD. (2, 
13, 14) Risk factors were reviewed by Tsuchiya et al. (15)  Some risk factors have been clearly 
linked to BPD, while further studies are needed to examine others.  It has been established that 
10-15% of adolescents with recurrent major depressive episodes will develop BPD.  Women 
have an increased susceptibility to episodes in the postpartum period (within four weeks of 
delivery). (2) Having a family history of affective disorder is also a major risk factor. (15) 
Demographic factors as risk factors for BPD were reviewed in a 2003 study by Tsuchiya 
et al.  As mentioned above, no association is suspected between male or female gender and 
prevalence of BPD, and studies of prevalence of BPD in different ethnic groups have had 
inconsistent results. (15) 
Tsuchiya et al. also reviewed the literature relating to pregnancy and BPD.  Suggestive 
findings have been reported for association between BPD and a history of pregnancy or birth 
complications, but the data are too limited to make a conclusion.  No association is suspected 
between prenatal (second trimester) maternal influenza infection and BPD.  While there is no 
conclusive evidence, there are suggestive findings for an association between winter-spring birth 
and the development of BPD.  No association is suspected between urban birth and BPD or birth 
order and BPD.  Again, there is an increased susceptibility to episodes in the immediate post-
partum period. (15) 
In a review of personal background factors, a number of studies exist that found no 
association between premorbid IQ and BPD, and handedness and BPD, although these factors 
have not been sufficiently evaluated.  A limited number of studies found an association between 
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dysfunctioned premorbid adjustment and poor behavior in school with BPD, although, again, 
these factors have not been sufficiently evaluated. (15)  
Inconsistency remains in studies of the association of BPD with some socioeconomic 
factors including education and occupation of the individual and of the parents.  There is an 
apparent association between BPD and other socioeconomic factors including lower income, 
unemployment, single marital status, and urban residence, although these are most often 
considered consequences of BPD status rather than predisposing risk factors.  Some studies 
suggest that there is an association between recent stressful life events and BPD, but further 
research is needed. (15) 
Regarding family background, some studies have found associations between BPD and a 
disturbed parent-child relationship and between BPD and early parental loss, but other studies 
have failed to confirm this association. (15) 
Finally, evidence for an increased risk of BPD for individuals with a history of another 
medical condition has been examined.  Some suggestive findings have been reported for an 
association between traumatic brain injuries and BPD and multiple sclerosis and BPD.  
Inconsistency remains in studies of seizure disorders and the risk of developing BPD. (15)  
Individuals with bipolar disorder have been shown to have higher rates of positive anti-thyroid 
antibody titers. (13)  Hypothyroidism has been shown to be associated with rapid-cycling bipolar 
disorder. (14) 
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2.6 COMPLEX GENETIC DISORDERS 
BPD is a complex genetic disorder.  Complex genetic disorders, or multifactorial disorders, are 
common in the general population.  Neither the genetic nor the environmental contribution alone 
is sufficient to cause the disorder; therefore, the disease concordance is less than 100% in 
monozygotic twins.  Severity varies greatly among affected individuals.  The pattern observed in 
families and the implications for the family are different than for Mendelian disorders.  The risk 
to second- and third-degree relatives is significantly less than the risk in Mendelian disorders.  
Affected individuals may be found in both the maternal and paternal lineage.  There may be a 
number of alleles that increase susceptibility; therefore, the contribution of a single genetic 
variant may be quite small.  This raises the concern of feasibility and value of testing for these 
genetic variants, once they have been identified. (16) 
2.7 EVIDENCE FOR A GENETIC COMPONENT IN BPD AND EMPIRIC RISK 
Family, twin, and adoption studies provide strong evidence for a heritable component to BPD.  
(2, 17)  Family studies can determine if a disease aggregates in a family, but cannot distinguish 
between genetic and environmental risk factors, because families have both genetics and shared 
lifestyles in common.  Twin and adoption studies are used to control for environment, and 
examine the rate of disease when environment is shared or environment is not shared. 
Family studies, prior to the mid-1960s did not make a distinction between bipolar and 
unipolar affective disorders, but showed familial aggregation for mood disorders overall.  In 
reviewing literature through 2006, Craddock and Forty found that the heritability of BPD is 80-
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90%. (10)  The monozygotic twin concordance is 45-70%. (10, 18)  The dizygotic twin 
concordance is about 20%. (18)  As mentioned above, the less-than-100% concordance rate in 
monozygotic twins suggests that environmental factors contribute to the disorder. 
An empiric risk is the risk that a disorder will develop in an individual based on 
observation of past events in a number of families affected with the disorder.  Craddock and 
Forty found that the recurrence risk in the sibling of a proband is 5-10%. (10)  A review of 
literature in 2004 by Shih, Belmonte, and Zandi found the rate of BPD in first-degree relatives to 
be 3-15%. (18)  The empiric risk for first-degree relative to develop bipolar II disorder is 1-5%. 
(2)  The Psychiatric Special Interest Group of the National Society of Genetic Counselors 
(NSGC) reviewed empiric risk literature in 2006. (19)  The results are reported in Table1. 
 
 
 
Table 1: Empiric Risks, reviewed by the NSGC Psychiatric Special Interest Group (19) 
Relationship to affected individual Empiric Risk 
Any first degree relative 5-30% 
Parent 10% 
Sibling 13% 
Child (one parent affected) 15-30% 
Child (one parent affected) AND one affected sibling 20% 
Child (both parents affected) 50-60% 
Second degree relative 5% 
2.8 GENETICS 
No major susceptibility genes have been identified by linkage or positional cloning, but there is 
support for several loci being associated with BPD.  Studies have shown linkage to 
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chromosomes 4, 12, 13, 18, 21, and 22. (17)  There is evidence for linkage at 6q21-q25 and 
12q23-24 in several studies.  The latter region is also implicated in linkage to unipolar 
depression. [reviewed in (10)].  In 2002, Badner and Gershon found evidence by meta-analysis 
for susceptibility loci at 13q and 22q. (20)  In 2003, Segurado et al found susceptibility loci by 
meta-analysis at 9p22.3-21.1, 10q11.21-22.1, and 14q24.1-32.12. (21) 
Medications for bipolar disorder management focus on neurotransmitter systems such as 
the dopamine, serotonin, and noradrenalin pathways, although the pathogenesis is not completely 
understood.  Therefore, these pathways are being considered when looking for functional gene 
candidates.  Polymorphisms in five genes, monoamine oxidase A (MAOA), brain derived 
neurotrophic factor (BDNF) on 11p13, D-amino acid oxidase activator (DAOA) on 13q, catechol-
O-methyl transferase (COMT), and serotonin transporter (5HTT), have shown significant effect 
sizes in BPD in meta-analysis.  COMT has also been implicated in schizophrenia. (reviewed in 
(10)) 
While genetic testing for susceptibility to bipolar disorder is not yet available, researchers 
are hopeful that genetic testing can improve outcomes by allowing earlier detection, application 
of preventive strategies, and tailored treatments.  Additionally, information from genetic testing 
can be incorporated into reproductive decision-making. As with other genetic tests, the potential 
negative implications must also be considered. (22)  The following section includes a discussion 
of the positive and negative implications. 
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2.8.1 Genetic counseling 
The most often cited definition of genetic counseling was proposed by the American Society of 
Human Genetics (ASHG) and adopted by the National Society of Genetic Counselors (NSGC).  
It states:  
“Genetic counseling is a communication process which deals with the human problems 
associated with the occurrence, or the risk of occurrence, of a genetic disorder in a 
family. This process involves an attempt by one or more appropriately trained persons to 
help the individual or family (1) comprehend the medical facts, including the diagnosis, 
the probable course of the disorder, and the available management; (2) appreciate the way 
heredity contributes to the disorder, and the risk of recurrence in specified relatives; (3) 
understand the options for dealing with the risk of recurrence; (4) choose the course of 
action which seems appropriate to them in view of their risk and their family goals and 
act in accordance with that decision; and (5) make the best possible adjustment to the 
disorder in an affected family member and/or to the risk of recurrence of that disorder.” 
(23) 
 
Another definition of genetic counseling states:  
“Genetic counseling is a dynamic psychoeducational process centered on genetic 
information.  Within a therapeutic relationship established between providers and clients, 
clients are helped to personalize technical and probabilistic genetic information, to 
promote self-determination and to enhance their ability to adapt over time.  The goal is to 
facilitate clients’ ability to use genetic information in a personally meaningful way that 
minimizes psychological distress and increases personal control.” (24) 
 
Genetic counselors discuss clinical and human molecular genetics and reproductive options, and 
they provide compassionate therapeutic counseling for loss of personal control, bereavement, 
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self-esteem issues, isolation, and stigmatization. (25)  A guiding principle of genetic counseling 
is nondirectiveness, which emphasizes patient autonomy.   
Genetic counseling is commonly used in prenatal, pediatric, and cancer clinic settings.  
Some genetic counselors work in adult clinics.  Genetic counseling for bipolar disorder and other 
complex genetic disorders is expected to become more common as the demand for information 
grows.  The opportunity for a discussion of the recurrence risk exists in other settings, such as 
during a discussion of family history when BPD is not the primary reason for referral. 
Identifying one underlying goal of genetic counseling may be unrealistic.  In the past, 
some providers stated that the goal was to reduce the number of individuals affected with birth 
defects and genetic conditions. While this approach emphasized client-informed decision 
making, some individuals had the impression that using this information clients would have the 
same goals as practitioners.  In reality, families affected with genetic conditions are not always 
interested in preventing the occurrence of the condition in the family.  Another theme is helping 
clients cope with and adapt to genetic information, while understanding that scientific knowledge 
is only one way to interpret risk, and other factors affect an individual’s perception of risk.  Short 
term goals of genetic counseling are to ensure that a client is heard, encouraged, valued, 
supported, and attended to.  Long term goals are to improve communication about genetic issues 
within the family, to anticipate future feelings or experiences, and to clarify values underlying 
decisions and attitudes. It is often more difficult to assess the success of genetic counseling in 
regard to the long term goals. (25) 
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2.8.2 Genetic counseling and testing for psychiatric disorders 
Genetic counseling for psychiatric disorders may become a reality in the future because of their 
high prevalence, an increase in knowledge of genetic contributions to psychiatric conditions, and 
an increase in public awareness. (26)  Genetic counseling for psychiatric disorders is similar to 
other types of genetic counseling in some ways, but it also faces some unique challenges.  The 
goals of genetic counseling along with disease associated stigma, guilt, and shame and decisions 
regarding testing are addressed in the following sections. 
Barbara Biesecker wrote that the general goals for genetic counseling for common 
disease and psychiatric disorders are similar; that is:  
• To promote health-enhancing behaviors 
• To enhance accurate and useful risk perception 
• To facilitate adaptation to genetic risk 
• To prevent disease. (25, 27)    
Another important component of any genetic counseling session is to explore the family’s 
motivation for seeking genetic counseling, remembering that a discussion of recurrence risk may 
be the primary motivation for some families, while it may create apprehension for other families. 
(26) 
Psychiatric disorders are often associated with stigma, guilt, and shame.  “Stigma can be 
defined as a mark or label that sets an individual apart as being different in the negative sense, 
making them undesirable, and precipitating social rejection and discrimination.”  Stigma has a 
strong, negative impact on self-esteem and well-being, and associative stigma also has a negative 
impact on unaffected family members. (26)  In 1996, Smith et al. published a study that found 
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that 68% of respondents in a bipolar support group, 62% of medical students, and 47% of 
psychiatry residents rated BPD as highly stigmatizing. (28)  Some stigma remains from the 
eugenics movement in the 1900s to 1940s, which resulted in euthanasia or forced sterilization of 
individuals with health problems including mental illness.  In one study, most interviewees felt 
that having a genetic explanation did not affect the level of stigmatization associated with BPD.  
Most individuals felt that stigma is caused by the lack of awareness, understanding, and 
knowledge about mental illness in the community. A smaller number of individuals felt that a 
genetic explanation would help decrease stigmatization, and one of twenty-two individuals 
interviewed felt that it would increase stigmatization. (22) 
Guilt associated with psychiatric disorders may be attributed to misconceptions and past 
theories.  One theory, influenced by the work of Freud, attributes mental illness to instability in 
the care-giving relationship including physical distance, erratic patterns of behavior, or physical 
or emotional abuse. (26)  Other individuals feel guilt for passing on an increased disease 
susceptibility to their children.  These are just a few of the numerous explanations for disease-
associated stigma, guilt, and shame.  In a study of the implications of genetic counseling for 
psychiatric disorders, the majority of interviewees felt that having a genetic explanation reduced 
perception of control over one’s symptoms and self-blame. (22) 
Other considerations exist for psychiatric genetic counseling.  Of course, a genetic 
counseling session would include a complete medical and family history, confirming psychiatric 
diagnoses in other family members whenever possible. (29)  Because information on 
susceptibility genes is incomplete, testing is not yet available, and the environmental factors are 
not yet completely understood, recurrence risks provided to families are based on empiric risks 
and may represent a broad range. (26)  While empiric recurrence risks are helpful in establishing 
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an individualized risk, they represent averages that generally do not reflect variation in risk over 
time or for different individuals.  Empiric recurrence risks for psychiatric disorders are generally 
limited to include only a few first- and second-degree relatives from one side of the family.  
Unfortunately, in a family with more than one affected individual, empiric recurrence risks that 
reflect the specific family structure may not be available. (30)  Additionally, empiric risks are not 
yet available which take into account multiple distinct psychiatric diagnoses in a family.  This is, 
however, a common scenario for families.  Genetics professionals should seek out empiric 
recurrence risks that most closely match the family structure for a specific case. (30)   Research 
continues to examine how recurrence risk is influenced by characteristics of the affected 
individual, such as age at onset, sex, and severity of illness, characteristics of the individual 
seeking risk calculation, such as age, sex, and psychiatric history, and characteristics of the 
pattern in the family.   
As mentioned above, genetic counseling may have the unintended consequence of 
exacerbating or creating guilt, shame, or stigma.  Biological explanations may increase stigma by 
labeling affected individuals ‘genetically different’.  The multifactorial threshold model may be 
helpful to prevent this, by explaining that all individuals have risk factors, and some have enough 
risk factors that they are over the threshold; thus normalizing genetic variation.   
Genetic explanations may result in a deterministic view of disease for both the individual 
with the diagnosis and unaffected family members, thus diminishing hope for recovery and 
perceived importance of lifestyle choices and environment.  Thus, the importance of lifestyle 
choices and environment along with genetics must be emphasized in counseling of these patients 
and families. (26)  A 1999 study by Senior et al. examined parents’ responses to genetic test 
results for familiar hypercholesterolemia (FH) in their children.  FH is a genetic condition that 
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greatly increases the risk of cardiovascular disease.  In a qualitative analysis of the interview 
responses, Senior et al. found that when the screening test was perceived as detecting elevated 
cholesterol levels, it was perceived as familiar, dietary in origin, easily controlled, and minimally 
threatening.  However, when the test was perceived as a genetic test, the condition was perceived 
as uncontrollable and threatening.  The authors found these results to be consistent with the self-
regulation model of illness which suggests that how people think about illness is based on the 
way it is labeled. (31) 
Unlike other medical information, genetic information has implications for other family 
members.  Information from genetic counseling or genetic testing may be helpful to other family 
members, but in other cases this information may be unwelcome, potentially disrupting 
relationships within families. (29) 
If genetic testing for BPD were to become available, one of the goals of genetic 
counseling would be to promote an understanding of the benefits, limitations, and possible 
outcomes of the genetic testing and to make a decision of whether or not to have testing based on 
accurate information.  Genetic counseling often helps clients to explore possible outcomes to 
allow them to be more prepared to adjust to any outcome and to consider if testing is the right 
decision for them. (29) 
Once the family understands the risks, they can be prepared to intervene and seek 
professional help should an at-risk family member begin to exhibit symptoms of BPD.  
Unfortunately, this may also lead to anticipatory stigma, or assuming that actions and emotions 
are attributable to the genetic disorder when they may not be. (26)  It may be helpful to include a 
discussion of the difficulties and benefits of this heightened awareness in the genetic counseling 
session; to remind family members that it can be difficult to determine if a psychiatric illness is 
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emerging, but they can work with their doctors in the future, and they are in a position to 
anticipate these events. (26)  Referral to family counseling or other health care professionals may 
be helpful in some cases. 
As mentioned above, Skirton and Eiser remind us that “The information provided during 
the genetic counseling process may not be novel to the client, and will be received against a 
background of the client's previous knowledge about the condition.” (32)  Individuals and 
families may have personal explanations for the occurrence of a psychiatric disorder, based on 
lifestyle, environment, and experiences.  Skirton and Eiser explain that discovering the 
individual or family’s explanation for disease creates the opportunity to address the role of 
environment and genetics and to fit this new information into their existing belief system. (32)  
Another suggestion for genetic counseling for psychiatric disorders, but a familiar 
recommendation for genetic counseling in other situations, is to give individuals the opportunity 
to talk about their experiences as an affected individual or family member of an affected 
individual.  This may be the first opportunity for unaffected family members to speak with a 
professional about the recurrence risk and their experiences. (16) 
Studying the outcome of genetic counseling often involves measurement of knowledge, 
anxiety, depression, and health-related behaviors.  Data exist for the outcome of genetic 
counseling and testing for hereditary cancer, Huntington’s disease, myotonic dystrophy, familial 
hypercholesterolemia, and others, but the data are limited for psychiatric genetic counseling. (26)  
As principles of practice are developed for psychiatric genetic counseling, the short- and long-
term outcomes must be assessed to determine if the counseling is meeting its goals. 
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2.8.3 Genetic counseling providers 
A number of papers have been published asking the question ‘who is best suited to counsel 
psychiatric patients on the genetics of their condition?’  A 2006 article by Finn and Smoller 
concluded that both genetics professionals and psychiatrists would benefit from further education 
in psychiatric genetics as the demand increases for this type of information. (16)  Ultimately a 
multidisciplinary approach would likely be best, as is used in the prenatal, pediatric, and cancer 
model, where each part of the team could provide detailed information about their area of 
expertise, while understanding the roles of the other providers as well. 
A survey of psychiatrists, also by Finn and Smoller, published in 2005 assessed general 
knowledge of medical genetics, knowledge of psychiatric genetics, current practice patterns, and 
attitudes toward clinical and ethical dilemmas that may arise in the application of genetic 
knowledge in psychiatry.  The median scores for general genetic knowledge and psychiatric 
genetic knowledge were 44 percent and 33 percent, respectively.  Estimates of heritability for 
psychiatric disorders varied widely, suggesting that substantial difference in opinion persists on 
the contribution of genetics and environment to psychiatric disorders.  Overall, psychiatrists 
tended to underestimate the contribution of genetic factors to psychiatric disorders.  More than 
80% of psychiatrists surveyed felt that discussing genetic information with patients and their 
families is part of their professional role; however, less than 25% of those surveyed felt prepared 
or competent to discuss this information.  In many case examples, psychiatrists expressed that 
they would feel more comfortable referring to a genetic counselor rather than discussing the 
issue themselves, but more than 90% of those surveyed stated that they have referred two or 
fewer individuals for a genetic consultation in the past year. (33)  Most psychiatrists’ primary 
exposure to genetic information is in medical literature.  Seventy-seven to 93 percent of 
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psychiatrists surveyed would be interested in additional opportunities for education including 
continuing medical education courses, written and Web-based materials, and multidisciplinary 
consultation with colleagues. (33) 
2.8.4 Understanding of the genetic and environmental contributions to BPD 
A study by Meiser et al. published in 2005 reported a consensus among affected individuals that 
there is a strong genetic component for BPD.  Only one of twenty-two individuals interviewed 
felt that one could overcome the genetic predisposition to BPD. One of twenty-two individuals 
surveyed did not fully support a genetic model for BPD, based on personal experience. (22)   
Individuals who felt that the genetic contribution was large were more likely to express interest 
in genetic testing for susceptibility.   
The majority of individuals interviewed agreed that genetic and environmental factors 
interact to cause BPD.  Some of the risk factors described by participants included stressful life 
events, major life changes, childbirth, marital troubles, birth trauma and subsequent brain 
damage, difficult childhood, child abuse, sexual abuse, personality factors, seasonal effects, drug 
and alcohol abuse, and modeling behavior after an affected parent.  Most individuals felt that 
these environmental triggers were not sufficient to cause BPD, but may serve as triggers. (22)  
2.8.5 Demand for genetic counseling  
A number of studies have assessed the interest in genetic counseling in individuals with BPD.  
Several studies have also ascertained the opinion of first-degree relatives and spouses of 
individuals with BPD.  A 2006 literature review found that most patients, family members, and 
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clinicians are interested in genetic counseling for BPD.  Quaid et al. found that 75% of 
individuals with BPD would have genetic counseling if it were available. (34) 
2.8.6 Demand for genetic testing 
A larger number of studies have ascertained opinions about confirmatory genetic testing, 
predictive genetic testing in children and adults, and/or prenatal genetic testing for BPD or 
psychiatric disorders overall.  A 2006 literature review found that the majority of patients, family 
members, and clinicians support genetic testing for BPD, should it become available. (34)  
Survey questions often refer to hypothetical situations about genetic testing.  The hypothetical 
questions may not reflect the reality of future genetic testing, and individuals may act differently 
when making the actual decision.  Current rates of testing for Huntington’s disease, a severe late-
onset neurodegenerative disorder, are less than were predicted in early studies before the gene 
was identified. (35)  Additionally, some studies have made clear the predictive value and how 
results would be presented in the hypothetical genetic testing situations, whereas others have not, 
which would likely impact response to testing. 
2.8.6.1 Presymptomatic testing in adults 
In a study of individuals with BPD, general practice patients without psychiatric illness, and 
psychiatric trainees, there was a positive response in all groups to the development and 
availability of presymptomatic testing for adults.  87% of individuals with BPD supported 
testing, along with 79% of general practice patients and 69% of psychiatry trainees.  There was a 
statistically significant difference between BPD patients and psychiatry trainees. (36)  In another 
study, 43% percent of psychiatrists surveyed supported presymptomatic testing in adults with a 
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family history of bipolar disorder given a test with greater than 95% predictive probability. (33)  
In a qualitative study, twenty of twenty-two (90.9%) of affected individuals reported that they 
would have had presymptomatic genetic testing if it had been available and if it could have 
provided a definite answer.  The remaining two reported that they would only have had 
presymptomatic testing if an intervention were available to prevent the disorder.  In the same 
study, if presymptomatic genetic testing gave a probability of developing BPD, rather than a 
definitive answer, the majority of affected individuals surveyed would still have had testing.  
Those who would not have had testing expressed concerns of worry, uncertainty, and 
stigmatization. (22) 
2.8.6.2 Confirmatory genetic testing in adults 
85.4% of affected individuals surveyed said that they would definitely have confirmatory genetic 
testing, and 14.6% said that they probably would.  Of their unaffected spouses, 46.3% said that 
they would definitely have the test themselves, and 34.1% said that they probably would have 
the test.  There was a statistically significant difference in the interest in genetic testing between 
patients and their spouses. (35)  When psychiatrists were surveyed, 74 percent supported genetic 
testing to confirm a diagnosis. (33) 
2.8.6.3 Presymptomatic or confirmatory testing in children 
The response to testing in children varies across different studies.  Some of the factors that affect 
the number of positive responses include who is surveyed, the nature of testing (i.e. 
presymptomatic or confirmatory), the presence of a positive family history, and the availability 
of prophylactic treatments.  When asked about presymptomatic testing for children, 78% of 
patients were in favor along with 61% of general practice patients and only 19% of psychiatry 
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trainees. (36) In another study, 44% of psychiatrists supported predictive testing in 
presymptomatic children with a family history of the bipolar disorder, while 72% supported 
genetic testing to confirm a diagnosis in a child. (33)  In another study, 83% of BPD support 
group members, 97% of medical students, and 89% of psychiatry residents would request 
presymptomatic testing for their children if prophylactic treatments were available.  In the 
absence of treatment options, 56% of participants would have their children tested (most 
interested were support group members, with 68% interested). (28)  Another study regarding 
presymptomatic testing of minors, 77.5% of affected individuals said that they definitely or 
probably should be tested, 12.5% were uncertain, and 10.0% said that they probably should not 
or definitely should not be tested. (35)  Another study found that half of affected individuals 
supported presymptomatic genetic testing of adolescents.  Nine percent of individuals in this 
study would only support testing in adolescents to confirm a diagnosis of BPD.  Some of the 
concerns about testing adolescents included the potential to alter parents’ behavior toward their 
children and the feeling that minors should not be tested until they have reached adulthood so 
that they can consent to testing themselves. (22)  It is logical that individuals with different 
backgrounds and exposure to BPD would have differing opinions regarding testing minors.  It is 
interesting that, overall, affected individuals are the most receptive to presymptomatic testing in 
the absence of treatment options, while medical professionals are more receptive to confirmatory 
testing or presymptomatic testing in the presence of treatment.  This may be because some 
affected individuals are wary of the treatment options or success of treatment because of personal 
experience.  Affected individuals may be more receptive to presymptomatic testing because of 
misdiagnosis in the past or because of their acceptance of the disorder. 
 30 
2.8.6.4 Prenatal genetic testing 
Extensive research has been done to explore opinions about prenatal genetic testing for BPD and, 
in some studies, pregnancy termination when the fetus has a confirmed susceptibility to BPD.  
While most professionals are in agreement that offering prenatal testing for genetic disorders is 
appropriate in the case of severe disorders such as Tay Sachs or when an intervention is 
available, a consensus has not been reached on offering prenatal genetic testing for other 
disorders or disabilities. (37)  
  A study by Milner et al., published in 1998, found that the majority (59-77%) of young 
adults support prenatal genetic testing for psychiatric disorders and behavior that may result in 
harm to others.  They were less likely to support prenatal genetic testing for personality 
attributes, intelligence, sexual preference, and characteristics such as height and weight. (38)  A 
follow up study again found less support for prenatal testing for sexual preference, violent, 
aggressive behavior, impulsive, risk-taking behavior, and low normal intelligence.  This study 
also found that men were significantly more likely to support prenatal genetic testing for 
psychiatric disorders and behavior than women, and mental health professionals were more 
likely to support prenatal testing for disease phenotypes or human traits when curative gene 
therapy was available. (39)  In both the original study and the follow-up study, unilateral support 
for, or disagreement with, prenatal testing for any one condition did not exist. (38, 39)   
In another study, however, the majority of individuals surveyed did not support prenatal 
testing for BPD, including 13% of psychiatry trainees, 29% of BPD patients, and 35% of general 
practice patients without a psychiatric disorder. (36)  Some studies show a difference in support 
for prenatal testing depending on family history, although most studies did not make this 
distinction.  In one such study, 58% of psychiatrists supported prenatal testing in affected 
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families, given a test with a high predictive probability (>95%).  Only fourteen percent of 
psychiatrists surveyed supported prenatal testing in the general population. (33)  When asked if 
they would pursue prenatal testing of a fetus, 43.9% of patients and their spouses said that they 
probably or definitely would, about 16% were uncertain, and about 40% said that they would 
probably not or definitely not. (35)  In another study, however, only 13.6 percent of affected 
individuals surveyed supported prenatal testing.   Some of the reasons given why participants 
opposed prenatal testing included opposition to pregnancy termination and not considering BPD 
severe enough to warrant pregnancy termination, especially with improving treatment options.  
Some individuals raised the concern that BPD could be eliminated from the population, thus 
depriving humanity of the positive contributions of individuals with BPD. (22)  
In 1996, Smith et al. published a study that examined the likelihood of terminating a 
pregnancy if prenatal testing showed a predisposition to BPD. (28)  The decisions surrounding 
termination seemed to be influenced by the likelihood of developing BPD, the anticipated course 
of illness, and projected clinical manifestations.  In each of the three groups (BPD support group 
members, medical students, and psychiatry residents), the percentage of individuals who would 
terminate a pregnancy increased with the likelihood that the child would develop BPD.  For each 
level of likelihood, the support group members were least likely to report that they would 
terminate the pregnancy, while the residents were most likely to report that they would terminate.  
When the risk for the fetus was 25% of developing BPD, less than 10% of each group reported 
that they would terminate.  If the risk for the fetus was 100%, about 35% of support group 
members reported that they would terminate the pregnancy, followed by 40% of medical 
students, and about 55% of psychiatry residents.  It is noteworthy that 82% of total respondents 
reported that they would terminate a pregnancy with another life threatening or severely 
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debilitating disorder. (28)  In another study, 55.0% of individuals with bipolar disorder and 
65.0% of their unaffected spouses said that they definitely would not choose abortion should the 
fetus have a known predisposition to BPD.  The majority of participants would not choose 
abortion in a number of genetic risk circumstances.  In the case of a “serious, painful, and 
incurable neurological disorder beginning at age 40,” 22.0% of patients and 24.4% of their 
spouses would choose abortion. (35) 
2.8.6.5 Perceived benefits and risks of genetic testing for BPD 
Other studies have asked participants to consider the benefits and risks of genetic testing for 
BPD.  In a quantitative study, individuals were asked to choose, from a list of options, the most 
important benefits of genetic testing.  The majority of patients and their spouses (67.5%) 
indicated that “to obtain treatment to prevent attacks” was the most important benefit to genetic 
testing.  The second most important reason benefit selected was “I think that I have the gene (or 
my spouse has the gene), and I want to be more certain of that.” (35)  In a qualitative study 
examining perceived benefits of genetic testing for BPD, benefits mentioned included the 
potential to prevent the onset of BPD, early intervention (particularly during adolescence), 
advancing research, providing a basis for pharmacogenomics (tailoring medication to a particular 
genotype) and thus potentially improving treatment outcomes, providing a basis for reproductive 
decision-making, a basis for decision to marry or not to marry an individual, increased certainty 
(confirmation of the diagnosis), potential for early diagnosis, and ability to avoid stressors or 
triggers for BPD associated episodes. (22)   
In the quantitative study mentioned above, 25% of patients felt that there was no risk to 
genetic testing for BPD.  Of those who felt that there were risks, the majority felt that the most 
important risk was that their insurance company may learn the results.  Among spouses, the most 
 33 
important risks were that the insurance company may learn the results and that a positive test 
may upset them because of worries about their children.  The majority of patients and their 
spouses felt that the benefits outweighed the risks for genetic testing, 22.0% of patients and 
14.6% of their spouses were uncertain.  None of the participants indicated that the risks of testing 
outweighed the benefits. (35)  In the qualitative study, risks of genetic testing mentioned 
included increased stigmatization, uncertainty associated with genetic test results communicated 
as a probability, increased worry among asymptomatic individuals carrying susceptibility genes, 
insurance discrimination, discrimination by employers, test results impacting reproductive 
decisions, lowered threshold for stress, increased vulnerability, and potential increased risk of 
suicide. (22)  When considering genetic testing for psychiatric conditions overall, Milner et al.’s 
1999 study elicited concerns including misuse of genetic information, employment 
discrimination, insurance discrimination, “eugenics”, and over-interpretation of genetic 
information.  (39)  
2.8.6.6 Other feelings toward genetic testing for BPD 
In the survey be Tripitelli et al., 92.1% of affected individuals and 78.9% of their spouses said 
that they would definitely or probably have chosen to marry their current spouse even if genetic 
testing had detected a gene for bipolar disorder.  In the same study, 55.0% of patients and 57.5% 
of their spouses said that positive genetic test results would definitely not or probably not have 
deterred them from having children. (35)  In a qualitative study, affected individuals reflected 
upon the effect of having a family with a high density of BPD diagnoses, and how this affected 
their reproductive decisions.  Some individuals were deterred from having children because of an 
increased risk of BPD, while others felt BPD was not severe enough to affect reproductive 
decisions.  About half of individuals reported that genetic testing would impact their decision to 
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have or not to have children. (22)  The majority of individuals surveyed (75.0% of patients and 
65.0% of their spouses) would want their genetic test results to be shared with their doctor.  
While the majority of individuals surveyed (76.9% of affected individuals and 84.6% of their 
spouses) would not want the genetic test results to be available to their insurance company. (35) 
Trends suggest a strong likelihood that there will be interest in genetic testing for bipolar 
disorder if it becomes available, including presymptomatic testing.  Should genetic testing 
become available, it is unlikely that genetic counselors will be able to precisely predict the 
course of BPD and will convey the fact that it is variable. (28)   
2.8.6.7  Health beliefs and BPD 
The Health Belief Model is a psychological model that attempts to use individuals’ beliefs to 
explain and predict their health-related behaviors.  The variables used in the Health Belief Model 
are summarized in Table 2. 
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Table 2: Variables Used in the Health Belief Model 
Variable Description 
Perceived threat   
        Perceived severity 
Feelings concerning the seriousness of developing a 
condition or leaving it untreated (medical and social 
consequences) 
        Perceived susceptibility Subjective perception of risk 
Perceived benefits The believed effectiveness of strategies used to reduce the burden of disease 
Perceived barriers 
Negative consequences that may occur if a particular 
health action is taken (physical, psychological, or 
financial) 
Cues to action Bodily or environmental events that motivate an individual to take action 
Other variables Indirect effects of sociopsychological, demographic, and structural factors 
Self-efficacy The individual's belief that they can successfully execute the behavior 
 
 
A 2007 study by Powell et al. examined the relationship between health literacy, diabetes 
knowledge, and patients’ readiness to take health action among individuals with type II diabetes.  
Low health literacy is associated with poor disease-related knowledge, poor self-management, 
poor adherence to treatment, worse self-reported health status, 30-50% increased risk of 
hospitalization, and higher annual health care costs.  The study found no association between 
health literacy level and diabetes health belief model score.  That is, regardless of health literacy 
level, individuals with type II diabetes were still willing to take action to manage their diabetes.  
Specifically, the study found that, on average, individuals with type II diabetes believed that 
diabetes was severe, that therapy is beneficial, and that they can overcome barriers to care. (40)  
A 2007 study examined lifestyle changes and the health belief model for women with BRCA1 
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and BRCA2 mutations.  These mutations are consistent with a lifetime risk of breast cancer of up 
to 87 percent and a lifetime risk of ovarian cancer of up to 44 percent.  This study found that 
most women made healthy behavior changes as a result of elevated risk awareness. (41) 
Tripitelli et al. surveyed individuals with BPD and their spouses in a 1998 study.  The 
questions were directed at assessing knowledge and understanding attitudes.  Individuals were 
asked about rates of response to treatment.  An estimated 60-70% of individuals with BPD have 
a good response to mood stabilizers such as lithium or anticonvulsants.  Individuals with BPD 
estimated that 56.7% of individuals have a total or excellent response to medical treatment.  The 
estimate was 52.6% among their spouses.  The estimate of having a good response to treatment 
was 61.5% in affected individuals and 59.5% in their spouses.  Individuals with BPD estimated 
that 25.9% of individuals have a poor response or no response to treatment, while the estimate 
among their spouses was 30.3%. (35)  In another study, researchers assessed the perceived 
efficacy of lithium, one of the most common treatments for BPD.  Overall, participants ranked 
lithium as quite helpful (4.4 on a scale of 1-5, with 1 being not helpful and 5 being very helpful).  
The majority of participants would use prophylactic treatment if it could reduce the severity of 
BPD by 50% or more. (28) 
In a 2001 study, individuals with BPD were asked to describe the cause of their BPD.  
74% cited genetics and/or a chemical imbalance (77%) as the causative factor, others cited stress 
(16%), breakup of relationships (3%), home life during childhood (3%), financial instability 
(3%), and lack of concern of mental health professionals (3%) as factors.  Patients were asked to 
estimate the incidence of BPD in the general population; the mean estimated risk was 28.11%, 
compared to the 3-24% risk established by recent research.  (2, 10, 18, 34) 
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Based on Mendelian inheritance, when one parent has one copy of a genetic variant, the 
chance that a child will inherit the variant is 50%, but it appears that BPD follows a 
multifactorial pattern of inheritance.  When asked about the chance that a child would inherit a 
gene for bipolar disorder, if one parent has that gene, the mean estimate was 46.7% for patients 
and 41.4% for their spouses.  An estimate of 30.5% was found for the likelihood that an 
individual could have a gene for bipolar disorder but not show symptoms. (35)  In another study, 
affected individuals were asked about the risk to their family members on a scale from very low 
to very high.  Most participants described their siblings’ and children’s risk as moderate or high.  
The mean quantitative risk for siblings was 35.2% and the risk for children was 44.6%.  Most 
participants described their parents’ risk as very low, with a mean quantitative risk of 20.4%.  
The risk to spouses was described as low to very low, with a mean quantitative risk of 12.1%. 
(34) 
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3.0  MATERIALS AND METHODS 
3.1 DESIGN AND RATIONALE 
This study was designed as the United States component of a study titled “Neurological 
Endophenotypes in Psychiatric Genetic Research in India.”  This larger study will test several 
hypotheses regarding bipolar disorder and schizophrenia.  One hypothesis is that “genetic 
counseling will help families cope with their mental illnesses”. (42)  Components of this study, 
including the knowledge and health belief survey, will be given to the participants in India as 
part of the genetic counseling component.  In future studies, the results of this study may be 
compared to the results in India to determine whether the needs and findings differ for the two 
patient populations. 
3.2 PARTICIPANTS 
Participants were recruited through two ongoing research studies (Candidate Gene Alleles and 
Genetic Determinants of Bipolar Disorder) through the University of Pittsburgh and Western 
Psychiatric Institute and Clinic (WPIC).  Research participants come from a number of sources 
across Pennsylvania, Ohio, West Virginia, Kentucky, and Michigan including referral from 
clinicians and drop-in centers partnered with WPIC and flyers and brochures posted at these 
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sites.  Additionally, researchers at WPIC present at conferences, meetings of the National 
Alliance on Mental Illness (NAMI), and the Pennsylvania Mental Health Consumers 
Association, and they recruit participants from these events.  Finally, participants may also be 
recruited by written or electronic flyers and brochures in the community or the recruitment 
website maintained through the University of Pittsburgh. (43, 44)   Individuals participating in 
the Candidate Gene Alleles or Genetic Determinants of Bipolar Disorder study were asked if 
they would like to hear about other studies, during the informed consent process. (44)  
Individuals were then given the Diagnostic Interview for Genetic Studies (DIGS), a 
comprehensive, semi-structured interview eliciting details on demographics, medical history and 
all major psychiatric disorders including mood disorders, substance abuse and dependence, 
psychosis, and anxiety disorders, along with standard clinical rating scales (the Mini Mental 
State Examination [MMSE], Scale for the Assessment of Positive Symptoms [SAPS],  Scale for 
the Assessment of Negative Symptoms [SANS], Supports Intensity Scale [SIS], and the Global 
Assessment Scale [GAS]). (45)  Upon completion of the diagnostic interview, subjects were 
given a recruitment flyer for this study.   
Inclusion criteria included: (1) Age 18 years or above, (2) Self-reported diagnosis of 
bipolar disorder or first-degree relative of an individual with a self-reported diagnosis of bipolar 
disorder.  The racial, ethnic, and gender characteristics of the proposed study population reflect 
the demographics of the regions from which participants were drawn (Pennsylvania, Ohio, West 
Virginia, Kentucky, and Michigan).  No exclusion was made based on race, ethnicity, gender, or 
HIV status. 
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3.3 EXPERIMENTAL DESIGN 
The experimental design was approved under expedited review by the University of Pittsburgh 
Institutional Review Board (IRB) under IRB number 0610128 in 2007 (Appendix A).  An 
anonymous survey (Appendix B) was administered to each participant after verbal informed 
consent was given and documented.  All contact with participants was over the telephone.  The 
survey was designed to measure familiarity with, and interest in, genetic counseling, knowledge 
of bipolar disorder, and health beliefs.  The survey also ascertained demographic information and 
a brief psychiatric history.  Knowledge of BPD was assessed using eight multiple-choice 
questions.  The knowledge survey was modeled after a survey administered to school-age 
children and women of childbearing age to assess knowledge of sickle cell disorder (46, 47)  The 
health belief survey was modeled after surveys used among women to assess motivations for 
participation in cancer screening programs and a survey administered to women of childbearing 
age to assess health beliefs regarding sickle cell disease and sickle cell trait. (47-49)  Both the 
knowledge and health belief surveys were adjusted to apply to bipolar disorder for the study 
“Neurological Endophenotypes in Psychiatric Genetic Research in India”. (42)  The health belief 
survey used a five-point Likert scale response system to assess perceived susceptibility, 
perceived seriousness, perceived benefit of action, and perceived barriers to action.  A score of 
one corresponded to “strongly disagree” and a score of five corresponded with “strongly agree” 
as recommended by Champion. (50, 51)  The final set of questions was a set of five open-ended 
questions encouraging a discussion of the causes of bipolar disorder and the likelihood that there 
is a genetic component. 
 Every other individual who completed the survey was offered participation in a brief 
educational session followed by an identical survey.  The rationale behind this approach was that 
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the first data set provides information on the patient population among the general population.  
The second data set would allow comparative analysis of the data to see if knowledge, health 
beliefs, or opinions changed. 
 The educational session was a semi-structured discussion of genetic counseling, genetics, 
multifactorial inheritance, empiric risk for bipolar disorder, and general information about 
bipolar disorder.  Participants were encouraged to ask questions, which the interviewer answered 
to the best of their ability, looking up the information if necessary. 
 Telephone interviews were selected as the sampling method because it allowed inclusion 
of participants who would not have otherwise been able to attend a face-to-face interview or 
focus group (e.g. those living in rural areas or living a great distance away).  An additional 
benefits of this method is that some participants may perceive and greater degree of anonymity, 
thus increasing the validity of their responses. (22)   Alternatives would include face-to-face 
interviews, which would have allowed for observation of non-verbal cue and responses and may 
have built more trust with the interviewer, or focus groups.  One of the benefits of focus groups 
is the synergistic effect resulting in production of ideas that might not otherwise be elicited. (22)  
However, with focus groups, some of the anonymity is lost.   
3.4 DATA ANALYSIS 
Data from affected individuals and first-degree relatives was analyzed separately to determine if 
there was a significant difference in knowledge, health beliefs, or acceptance of genetic 
counseling.  Answers to the knowledge questions were transformed into dichotomous variables, 
with correct answers coded as one and incorrect or unsure answers coded as zero.  The maximum 
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possible score for knowledge of BPD was eight.  Among individuals who participated in the 
educational session, the knowledge score before and after the session were compared using a 
paired t-test.  Familiarity with genetic counseling and acceptance of genetic counseling were 
measured and acceptance before and after the educational session were compared.  Linear 
regression was used to determine if demographic variables predicted level of knowledge or 
acceptance of genetic counseling prior to the educational session.  On the five-point Likert scale, 
the population mean for perceived severity of BPD, susceptibility, benefits of testing, and 
perceived barriers to testing were calculated, including a score for each component and a 
cumulative score for each category.  For individuals who participated in the educational session, 
the mean health belief scores were compared before and after the session.  Each health belief was 
analyzed with knowledge scores for correlation, and linear regression was used to determine if 
demographic characteristics predicted health beliefs.   
Answers to the open-ended questions and responses in the semi-structured interview were 
analyzed using constant comparative analysis developed for use in grounded theory 
methodology. (52)  While not developing a grounded theory, the goal was to identify themes and 
differences in responses to the open ended questions.  Each individual answer to a question was 
compared with all other answers to that question, and themes were identified and described.  A 
pattern is defined as a common topic, vocabulary, activity, or feeling.  Themes are pieced 
together to describe the collective experience.  When themes are identified, they are compared to 
the current literature in order to fit into the established framework or to show differences in the 
opinions of the population. 
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4.0  RESULTS 
4.1 DEMOGRAPHICS 
To date, four individuals have participated in this study.  The population surveyed were primarily 
over age 40 (100%), married (75%), and had one or more children (75%).  100% of participants 
were high school graduates, including 25% whose highest level of education was college and 
25% who had completed masters/doctoral/professional school.  To date 75% of individuals 
surveyed are female.  To date all individuals surveyed are affected with BPD, all are being 
treated with medication and outpatient therapy, and 50% have at least one affected first- or 
second-degree relative.  (See Figures 1-5.) 
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Age 41-45 18-20
25% 21-25
26-30
31-35
35-40Age 56-60 
50% 41-45
46-50
51-55
56-60
Age 46-50 65+
25% 
N = 4
 
Figure 1: Age Distribution of Preliminary Survey Participants 
 
Single 
25% 
Single
Married 
Widowed 
Divorced
Married 
75% N = 4
 
Figure 2: Marital Status of Preliminary Survey Participants 
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 0 children 
25% 
0 
1 
2 2 children 
50% 3 
4 
5+ 
1 child 
25% 
N = 4
Figure 3: Number of Children for Preliminary Survey Participants 
 
Graduate/Doctoral/ 
Professional School 
25% 
Some High School
High School Graduate
Some College
College Graduate
College 
Graduate 
Graduate/Doctoral/ High School 
Graduate Professional School 25%
50% 
N = 4
Figure 4: Highest Level of Education Completed Among Preliminary Survey Participants 
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Within the last
6 months
6-12 months
ago
1-2 years ago
3-5 years ago
5+ years ago
 
 
     5+ years ago 
     50% 
 
      3-5 years ago
                           50% 
   
                                                                        N = 4
 
 
Figure 5: Time of Diagnosis for Affected Individuals Completing the Preliminary Survey 
4.2 SPECIFIC AIM I 
The first specific aim was to determine the current health beliefs of those diagnosed with bipolar 
disorder (BPD) and the current health beliefs of their first degree relatives, in regard to cause, 
course, treatment, and genetic information.    
Four individuals diagnosed with BPD have been surveyed.  The cumulative perceived 
severity of BPD was high at 4.33 (±1.30), the cumulative perceived susceptibility to BPD was 
high at 4.45 (±1.29), the cumulative perceived benefit to genetic information was high at 4.36 
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(±1.29), and the cumulative perceived barriers to testing were moderate to high at 3.09 (±1.81) 
(Table 3). 
At this time the sample size does not permit correlation with demographic factors to be 
calculated.  Additionally, data from first-degree relatives are not yet available. 
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Table 3: Summary of Current Health Beliefs (Affected Individuals, N=4) 
 
Severity  Average 
Standard 
Deviation
Bipolar disorder is a serious 
disease. 5.00 0.00 
Having a child with bipolar 
disorder would be very scary. 4.00 1.15 
My life would change if my child 
had bipolar disorder. 4.00 2.00 
*Severity Cumulative 4.33 1.30 
Susceptibility     
My children are at risk for bipolar 
disorder. 4.50 1.00 
Bipolar disorder could happen in 
my family. 5.00 0.00 
My partner may be a carrier of 
genes for bipolar disorder. 3.67 2.31 
*Susceptibility Cumulative 4.45 1.29 
Benefit     
It is useful to know if I have genes 
that make bipolar disorder more 
likely. 5.00 0.00 
It is useful to know if my partner 
has genes that make bipolar 
disorder more likely. 5.00 0.00 
Knowing the risk of having a child 
with Bipolar disorder would 
change my plans about a future 
pregnancy. 3.25 1.71 
*Benefit Cumulative 4.36 1.29 
Barriers     
Genetic testing for Bipolar disorder 
is painful and difficult. 1.50 1.00 
My partner would be hard to 
convince to have genetic testing. 3.33 2.08 
I would not want to pay for genetic 
testing. 4.50 1.00 
*Barriers Cumulative 3.09 1.81 
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Qualitative analysis is severely limited by the small sample size.  Preliminary analysis is 
striking in that 3 of 3 people who answered the first question, “when you first heard about mental 
illness in your family, what did you think caused it?” attributed their BPD to environmental 
effects (Table 4), while they also all agreed that BPD is genetic.  One individual even stated, “I 
got this from my mother, she carried the gene, so I have it.”   
 
Table 4: Sample of Responses to Open-ended Question 1 
When you first heard about mental illness in your family, what did you think caused it?
"An imbalance of chemicals in my brain." 
"In my family, I would say events, life-changing events happened." 
"Well, I guess I had felt that mine was related to stress and, like, maybe a predisposition to 
feel depressed and melancholy in certain situations.  When I was under a lot of stress I began 
to experience more symptoms, so like, when I had some breakdowns and was hospitalized I 
relate them to stressful circumstances.  But, I feel like I had a predisposition." 
 
When asked how a hereditary condition might affect a family, an emerging theme, 
expressed by 2 of 4 interviewees is that it puts stress on the family.  One individual stated, 
 “We change how we do things, for example, with the medications and the mood swings,  
it effects your family severely.  As far as them knowing how to do what they need to do  
and the stress it puts on your family.  Embarrassment for the children.  Just the  
whole…pressure, just a lot of stress and pressure on the family.”   
Another emerging theme is that the realization that BPD is hereditary may explain the 
behaviors of other family members.  Two of four individuals surveyed expressed the belief that 
parents and/or grandparents had BPD but had gone undiagnosed. 
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4.3 SPECIFIC AIM II 
 
To assess participants’ knowledge of genetic counseling, and to assess acceptance of and interest 
in genetic counseling services and genetic testing. 
Four individuals diagnosed with BPD have been surveyed.  Preliminary data show that 
knowledge of genetic counseling is low, with no participants stating that they have heard of 
genetic counseling or know what it is, prior to the educational session.  Four of four individuals 
stated that they did not know if genetic counseling would be useful to them. 
4.4 SPECIFIC AIM III 
To improve the knowledge and acceptance of genetic testing and genetic counseling for 
psychiatric conditions through individual education sessions. 
Four individuals diagnosed with BPD have been surveyed.  Preliminary data show that 
the knowledge of BPD in affected individuals is high, with an average score of 7 correct (±1.15) 
out of a possible 8.  The lowest score to date is 6 correct and the highest score is 8 correct. 
Data are insufficient to determine if there is a significant difference in knowledge of BPD 
or in acceptance of genetic counseling before and after the educational session. 
At this time the sample size does not permit correlation with demographic factors to be 
calculated.  Additionally, data from first-degree relatives are not yet available. 
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5.0  DISCUSSION 
This study has examined the health beliefs, level of knowledge, and acceptance of genetic 
counseling in individuals with BPD and their first-degree relatives.  This study and similar 
studies are useful to medical professionals in determining the needs of this patient population as 
the demand for genetics services grows.  Additionally, the study has examined whether a brief 
educational session can improve knowledge or change acceptance of genetic counseling or health 
beliefs.  This will be helpful in establishing evidence that education is a helpful intervention, as 
the health belief model shows that health beliefs affect the willingness to take action in one’s 
own health care. Determining possible changes in acceptance of genetic counseling after the 
educational session has the potential to show that interest in genetic counseling services 
increases with just a brief discussion of the multifactorial inheritance pattern of BPD. 
The first aim was to determine the current health beliefs of those diagnosed with bipolar 
disorder (BPD) and the current health beliefs of their first degree relatives, in regard to cause, 
course, treatment, and genetic information.  The hypothesis was that participants would have a 
low level of knowledge about cause, high level of perceived severity of mental illness, and a low 
level of perceived susceptibility.   Preliminary data also show that the knowledge of BPD in 
affected individuals is, in fact, high.  Additionally, the perceived severity and level of 
susceptibility are high.  This information will be helpful in counseling for bipolar disorder.  High 
severity of BPD indicates that the majority of affected individuals felt that BPD is a serious 
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disease and having a child with BPD would have an impact on their life.  High susceptibility 
indicates that there is a risk to other family members. 
In considering bias to this data, because the individuals surveyed were recruited through 
another study of BPD and genetics, the population may have educated themselves or learned 
more about BPD through their participation in the other study.  Additionally, these individuals 
are aware that they are in a study of genetics and BPD.  This may help to explain the high level 
of perceived susceptibility and knowledge, as the participants have an understanding that the 
genetics of BPD is under investigation. 
In the qualitative analysis, it is striking that three of three individuals attributed their BPD 
to environmental factors, yet they agreed that there was a genetic component to BPD.  As more 
data are collected, it will be important to examine this theme.  If individuals have a strong 
preconceived belief about the cause of their disorder, it may be a barrier to successful genetic 
counseling.  Clients may feel that the genetic explanations and risks are reasonable, yet they do 
not explain what is happening in their family.   
The second specific aim was to assess participants’ knowledge of genetic counseling, and 
to assess acceptance of and interest in genetic counseling services and genetic testing.  The 
hypothesis was that participants would have a high level of perceived benefit to testing, a low 
level of perceived barriers to testing, a low level of perceived impact of genetic susceptibility 
information, and a low level of knowledge of and interest in genetic counseling. Identifying the 
current status of knowledge and acceptance will determine areas of education that must be 
stressed in order to increase knowledge and acceptance.  Preliminary data show that perceived 
benefit of genetic information was high, while the cumulative perceived barriers to testing were 
moderate to high.  The high perceived benefit of genetic information indicated that most affected 
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individuals would find genetic risk information useful.  Of note, preliminary data show that for 
one statement, “Knowing the risk of having a child with bipolar disorder would change my plans 
for a future pregnancy” the score was only 3.0 (±1.41) out of a possible 5.  Therefore, it may be 
that the perceived benefit of genetic information is high overall, but participants are less likely to 
change their reproductive plans if they have the information.  Another possible explanation is 
that individuals are less likely to agree with this statement because they may not plan to have 
another pregnancy for other reasons (age, marital status, socioeconomic status), thus their plans 
would not change.  The cumulative perceived barriers to testing were moderate to high.  
However, on average, participants disagreed with the statement that genetic testing is painful and 
difficult, with a score of 1.83 (±0.98).  Stronger perceived barriers involved cost and convincing 
their partner to have testing.  As hypothesized, the knowledge of genetic counseling is low. 
The third specific aim was to improve the knowledge and acceptance of genetic testing 
and genetic counseling for psychiatric conditions through individual education sessions.  The 
hypothesis was that lack of interest in genetics may be due to a lack of knowledge of genetics 
and the risks associated with bipolar disorder. Acceptance can be improved by increasing the 
communities’ knowledge of hereditary concepts. Acceptance of and interest in genetic 
counseling services may also increase.  These hypotheses will be further evaluated as more 
participants are interviewed and participate in the educational session. 
Studying the correlations between demographic factors and knowledge, health beliefs, 
and acceptance of genetic counseling can help medical professionals to better understand their 
patient population and tailor their message.  It may provide a starting point for further research to 
determine why these correlations exist or how this information can be used in the future.   
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It will also be helpful to study the correlation between knowledge of BPD and health 
beliefs.  The level of knowledge may affect the perceived severity of BPD, susceptibility to BPD, 
benefit of testing, and barriers to testing. 
As mentioned above, one limitation of this study is that individuals were invited to 
participate only after enrolling in another study.  Therefore, participants were all seeking medical 
care and/or attending meetings to seek information about BPD and psychiatric illness.  This 
limits the generalizability of the data.  The results may not reflect the knowledge, opinions, and 
health beliefs of individuals who are not currently seeking medical care.  Also, the individuals 
enrolled in this study may have more information regarding the genetics of BPD because of the 
nature of the studies in which they are enrolled at Western Psychiatric Institute and Clinic.   
As was discussed previously, there are limitations to making all contact with participants 
over the telephone.  Briefly, it may limit trust with the interviewer thus limiting full disclosure of 
beliefs during the open-ended interview.  While the educational session was modeled after a 
basic genetic counseling session, the interviewer was unable to detect non-verbal clues that the 
participant heard and understood the material.  Also, the interviewer was unable to use visual 
aids during the educational session to facilitate understanding. 
 
 
 
 
 
 
 
 55 
APPENDIX A 
INSTITUTIONAL REVIEW BOARD (IRB) APPROVAL LETTER 
 56 
 57 
 
APPENDIX B 
SURVEY 
B.1 DEMOGRAPHIC AND PSYCHIATRIC HISTORY QUESTIONNAIRE 
1. How old are you? 
 
 
2. What is your marital status? 
 
□ Single   
□ Married  
□ Divorced  
□ Widowed  
 
 
3. How many children do you have? 
 
□ 0   
□ 1   
□  2  
□  3  
□  4   
□  5+  
 
 
4. Do you live with your partner?  
 
□ Yes   
□ No   
□ I have no partner  
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5. What is the highest level of education you have finished? 
 
□ Some High School    
□  High School Graduate     
□ Some College    
□ College Graduate  
□ Graduate/Doctoral/Professional School   
 
 
6. Do you have, or have you had, bipolar disorder?  
 
  □ Yes     
□  No 
 
 
7. Do you have a relative who has been diagnosed with Bipolar disorder?  
 
   □ Yes      
□ No 
 
 
7b. If yes, which family member or family members have bipolar disorder? (all that  
apply) 
 
□ Myself      
□ Mother    
□ Father  
□ Child  
□ Adopted child  
□ Brother     
□ Sister  
□ Grandparent  
□ Aunt / Uncle (blood relation)  
□ Cousin 
□ Other (please state) ___________________         
 
 
Follow up questions for “affected subject with no affected first-degree relatives” and “affected 
subject with one or more affected first-degree relatives”: 
 
 
1. How long ago were you diagnosed?  
 
   □ In the last 6 months 
   □ 6-12 months ago 
   □ 1-2 years  
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   □ 3-5 years  
   □ 5+ years 
   □ Other       
    
 
2. When did you last actively have symptoms?  
 
  □ Currently in an active phase 
  □ In the last 6 months 
  □ 6-12 months ago 
   □ 1-2 years 
  □ 2-5 years 
   □ 5+ years 
   □ Other       
 
 
3. Are you currently being treated for Bipolar disorder?  
 
□ Yes  
  □ No 
 
 3b. If yes, what type of treatment? (all that apply) 
    □ Taking medication  
   □ In day therapy 
    □ In residential therapy (hospital) 
   □ Other       
 
 
4. Do you have any other psychiatric diagnoses?  
 
□ Yes 
   □ No 
  □ Do not know 
 
 4b. If yes, what is the diagnosis? 
 
    □ Personality disorder 
   □ Manic depression 
    □ Depression 
    □ Schizophrenia or Schizoaffective disorder  
    □ Other       
□ Do not know 
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B.2 GENETIC COUNSELING QUESTIONNAIRE 
13. Have you heard of genetic counseling?  
 
□ Yes       
□ No 
 
 
14. Do you know what genetic counseling is?  
 
   □ Yes    
□ No 
 
 
15. Have you ever had genetic counseling?  
 
   □ Yes    
□ No 
 
 
 16. If yes, was it due to a family or personal history of bipolar disorder? 
 
    □ Yes    
□ No 
 
 
17. Do you think genetic counseling would be useful to you?  
 
  □ Yes    
□ No 
 
 
Comments: 
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B.3 KNOWLEDGE QUESTIONNAIRE 
Following are some questions about Bipolar disorder. I will read each question to you, along 
with five possible answers.  Please select the one best answer for each question.  
 
1) Bipolar disorder is caused by  
a. dirty needles  
b. a virus  
c. inheriting genes from parents  
d. the exact cause is unknown currently  
e. none of the above  
 
2) How many genes must someone inherit to have Bipolar disorder?  
a. zero, it is not caused by genes  
b. one from their mom  
c. two, one from their mom, and one from their dad  
d.  the number of genes is not presently known  
e. none of the above  
 
3) Bipolar disorder can cause  
a. euphoria, feeling "high"  
b. racing thoughts, talkativeness 
c. drug or alcohol use 
d. inability to concentrate well 
e. all of the above  
 
 
 
 
 62 
4) Bipolar disorder is most likely caused by 
a. genes 
b. the environment such as a major life event 
c. a combination of genes and environment such as a major life event 
d. radiation 
e. none of the above  
 
  
5) Bipolar disorder is a serious conditions that causes shifts in  
a. mood 
b. energy  
c. functioning 
d. all of the above  
e. none of the above  
 
6) Bipolar disorder is present 
a. More in poor people 
b. More in rich people 
c. Same across all ethnic and economic groups 
d. More in some ethnic groups 
e. More in some regions 
 
7) Bipolar disorder is treated by  
a. medications known as mood stabilizers 
b. liver transplant  
c. rest  
d. blood transfusions  
e. none of the above  
 
8) How can you tell if someone carries genes for Bipolar disorder?  
a. They look sick  
b. They will eventually have Bipolar disorder  
c. With a simple blood test  
d. There is no way of knowing  
e. None of the above  
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B.4 HEALTH BELIEF ASSESSMENT 
Please rate your level of agreement with each of the following statements on a 5-point scale 
where 1 means “strongly disagree” and 5 means “strongly agree.”  
 
B.4.1 Severity   
 
1. Bipolar disorder is a serious disease. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
2. Having a child with bipolar disorder would be very scary. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
3. My life would change if my child had bipolar disorder. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
B.4.2 Susceptibility  
 
4. My children are at risk for bipolar disorder. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
5. Bipolar disorder could happen in my family. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
6. My partner may be a carrier of genes for bipolar disorder. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
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B.4.3 Benefit  
 
7. It is useful to know if I have genes that make bipolar disorder more likely. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
8. It is useful to know if my partner has genes that make bipolar disorder more likely. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
9. Knowing the risk of having a child with Bipolar disorder would change my plans about a 
future pregnancy. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
B.4.4 Barriers  
 
10. Genetic testing for Bipolar disorder is painful and difficult. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
11. My partner would be hard to convince to have genetic testing.  
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
 
12. I would not want to pay for genetic testing. 
 
 Strongly Disagree  1  2  3  4  5  Strongly Agree  
B.4.5 Open-ended questions 
13. When you first heard about mental illness in your family, what did you think caused it? How 
do you think it happened or occurred? 
 
14. When we say a condition might be inherited, what does that mean to you?  
 
15. How do you think a hereditary condition would affect your family now and in the future? 
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16. Do you think bipolar condition is hereditary? 
 
If response is Yes and you have bipolar disorder – what do you think your risk is for 
passing it on to a child?  
 
If response is Yes and you do not have bipolar disorder – what do you think your risk is 
for developing the condition?  
 
17. Do you have any other comments you would like to share? 
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APPENDIX C 
EDUCATIONAL SESSION OUTLINE  
a) Contracting: In this educational session we will discuss what is known and what is not 
known about the genetics and effects of bipolar disorder.  Please feel free to ask any 
questions that you may have.  This will be similar to a genetic counseling session. 
b) What is genetic counseling? 
i) Genetic counseling is a discussion of the genetic causes for a disorder, the chance that 
other family members will show signs and symptoms of the disorder, how the 
diagnosis may affect the family, and where people can go for more information. 
c) Genetic counseling usually involves a brief discussion of genetics. 
i) Genetics is the study of DNA.  You may have heard of DNA before, DNA is like an 
instruction manual for the body.  We each have our own, unique DNA code, but we 
also share some of that code with our family members.   
(1) We know that changes in the DNA can put people at risk for developing certain 
conditions.  
(a) For bipolar disorder, the exact causes are not completely understood, but at 
present it seems that both genetic and environmental factors may increase the 
risk of BPD. 
(b) Threshold model of multifactorial inheritance. 
(c) The number and exact locations of the predisposing genes are not known. 
(d) If you have one first-degree relative with BPD, your risk is about 3-15%, 
although some studies say the risk is as high as 24%. 
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ii) At present, there is no way to tell if a person carries genes that make them more 
susceptible to BPD.  You cannot tell by looking at someone, by a physical exam, or 
with genetic testing. 
d) What are the effects of BPD? 
i) BPD can affect moods, energy level, and functioning. 
e) Who does BPD affect? 
i) BPD affects about 1% of the population, current evidence suggests that it affects men 
and women equally, and the rate is equal across ethnic groups. 
f) Treatment 
i) Most individuals affected with BPD are treated with mood stabilizers.  Sometimes 
antidepressants are also prescribed.  Doctors work with their patients to find the best 
possible management. 
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